SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 3 — Focused Visit (Follow-up) — Mary Seacole — True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

PatientMary Seacole
Date of birth1805-11-23
IdentifiersMRN HR-NI027-SYN-TD; SSN (made up) 000-27-4483
Document date1877-04-13
AuthorAdwoa Fairweather-Kent, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Four-week review on two blood pressure medicines. [S]

History of Present Illness

Mary Seacole returns four weeks after starting amlodipine and chlorthalidone. Her headaches stopped in the second week. Her home readings average 134/80. She has had no dizziness on standing and no ankle swelling. She began physical therapy three weeks ago, does her exercises most days and uses the cane the therapist fitted, in her right hand. The occupational therapist visited and a rail is being fitted on the stairs to her rooms. She has met the social prescribing link worker, who found a tai chi class near her home. Her knees hurt less. She wants to talk about the cholesterol tablet. [S]

ElementDetail
Home readingsAverage 134/80 mmHg
HeadachesGone since the second week
Side effectsNo dizziness or ankle swelling
Knees and fallsPhysical therapy and a cane; no falls

Review of Systems

SystemResultFinding
NeurologicalNegativeNo headaches, weakness or numbness
CardiovascularNegativeNo dizziness on standing, palpitations or swelling
MusculoskeletalPositiveKnee pain 5 out of 10, better with exercise
GenitourinaryNegativePassing urine a little more in the mornings

4 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Diclofenac sodium 1% topical gel, 4 g rubbed into each painful knee up to four times a day4 g to each knee up to four times a dayTopical route1877-03-09activeS
Amlodipine 5 mg oral tablet, one tablet dailyOne tablet dailyOral route1877-03-16activeS
Chlorthalidone 12.5 mg oral tablet, one tablet each morningOne tablet each morningOral route1877-03-16 to 1877-05-11completedS
Atorvastatin 20 mg oral tablet, one tablet dailyOne tablet dailyOral route1877-04-13activeS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
1877-04-13Body height157cmS
1877-04-13Body weight77.6kgS
1877-04-13Body mass index (BMI) [Ratio]31.5kg/m2S
1877-04-13Systolic blood pressure138mm[Hg]S
1877-04-13Diastolic blood pressure82mm[Hg]S
1877-04-13Heart rate76/minS
1877-04-13Respiratory rate16/minS
1877-04-13Body temperature36.6CelS
1877-04-13Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
1877-04-13Sodium [Moles/volume] in Serum or Plasma136mmol/L135-145 mmol/LNormalS
1877-04-13Potassium [Moles/volume] in Serum or Plasma3.7mmol/L3.5-5.1 mmol/LNormalS
1877-04-13Creatinine [Mass/volume] in Serum or Plasma0.95mg/dL0.59-1.04 mg/dLNormalS
1877-04-13Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 1872)/1.73 sq M64mL/min/{1.73_m2}>=60 mL/min/1.73 m²NormalS
1877-04-13Glucose [Mass/volume] in Serum or Plasma94mg/dL70-99 mg/dLNormalS
1877-04-13Left ventricular Ejection fraction64%50-70%NormalS
1877-04-13Pain severity - 0-10 verbal numeric rating [Score] - Reported5{score}S
1877-04-13Total interval score [KOOSJR]56.6{score}S

Physical Exam

Vital signs recorded on 1877-04-13; see the Vital Signs section. [S]

SystemFinding
GeneralWell; blood pressure 138/82 seated, 134/80 standing at three minutes, pulse 76; weight 77.6 kg
CardiovascularRegular rhythm; no murmur; no edema
MusculoskeletalNo knee effusion; Timed Up and Go 14 seconds with the cane

Problems

ProblemClinical statusVerificationCodeProvenance
Headaches on waking for three weeks and blood pressure 184/102 mmHg at the visit (average of two seated readings with a large cuff); no chest pain, breathlessness, visual loss, confusion or weakness; fundi with arteriolar narrowing but no hemorrhages or papilledema; no hypertensive emergency; hypertension not yet confirmedresolvedprovisional R03.0S — Synthetic presenting problem; resolved into stage 2 hypertension when a week of home readings confirmed it. Not a claim about her real health.
Stage 2 hypertension confirmed by home readings (seven-day average 168/96 mmHg), with left ventricular hypertrophy by ECG voltage; no albuminuria; 10-year cardiovascular risk about 14%; treated to reduce the risk of stroke, heart failure and kidney diseaseactiveconfirmed I10S — Synthetic modern diagnosis made at the second visit. It is linked to the recorded apoplexy before her death only as the reason for the stroke-prevention teaching; the record does not claim that she had hypertension.
Bilateral primary knee osteoarthritis, worse on the left: pain on stairs and on rising from a chair, morning stiffness under 30 minutes, crepitus and bony enlargement without warmth; clinical diagnosis without imagingactiveconfirmed M17.0S — Synthetic modern problem; not a claim about her real health.
Fall risk: one fall in the past year, a trip on the outside steps without injury; afraid of falling and going out less; STEADI screen positive; Timed Up and Go 15 secondsactiveconfirmed Z91.81S — Synthetic fall-risk problem.
Obesity, class 1 (BMI 31.6); she calls herself stout and wants to lose some weight for her kneesactiveconfirmed E66.811S — Synthetic modern problem; her self-description as stout is documented, her weight is not.

Assessment and Plan

Protocol monitoring: items the monitoring protocol calls for at this visit. [S]

DomainMeasureIntervalStatusDetail
ExaminationBlood pressure in the clinic (seated, large cuff, two readings) and at home; target below 130/80 mmHgEvery visitCompleted today138/82 mmHg; home average 134/80
ExaminationOrthostatic blood pressure (lying and standing)Every visitCompleted todayNo orthostatic drop
ExaminationWeight and BMI (5% weight-loss goal for knee osteoarthritis)Every visitCompleted today77.6 kg, BMI 31.5
ExaminationCardiac auscultation and edemaEvery visitCompleted todayNo murmur; no edema
LaboratorySodium, potassium, creatinine and eGFRTwo to four weeks after starting or changing a diuretic or ARB; then every six months on these medicinesCompleted todayFour weeks after chlorthalidone: sodium 136, potassium 3.7, creatinine 0.95 mg/dL (eGFR 64), glucose 94
ImagingEchocardiogramAt diagnosis if stage 2 or left ventricular hypertrophyCompleted todayEjection fraction 64%; mild concentric left ventricular hypertrophy; grade 1 diastolic dysfunction
LaboratoryLipid panelFour to twelve weeks after starting a statin, then yearlyOrderedAtorvastatin 20 mg started today; panel in four to twelve weeks
SurveyKnee pain score (0 to 10)Every visitCompleted today5 out of 10
SurveyKnee function (KOOS JR)Every visitCompleted todayKOOS JR 56.6
ExaminationKnee examination (range of motion, effusion, alignment, crepitus)Every visitCompleted todayNo effusion
Self-managementExercise therapy, tai chi and self-managementOngoingCompleted todayPhysical therapy for three weeks; home exercises most days; cane in the right hand
Medication safetyNSAID safety (topical diclofenac; no oral NSAIDs)Every visitCompleted todayDiclofenac gel only
ExaminationSTEADI assessment: Timed Up and Go, 30-second chair stand, 4-stage balanceAt diagnosis of fall risk, then yearly or with a fallCompleted todayTimed Up and Go 14 seconds
Medication safetyMedicine review for fall risk and interactions (Beers criteria)Every visitCompleted todayChlorthalidone sodium check done; atorvastatin added
Self-managementHome safety, footwear, vision and assistive deviceAt diagnosis of fall risk, then yearlyCompleted todayOccupational therapy visit done; stair rail being fitted; bath board supplied
Self-managementHer own remedies: interactions and how she uses themEvery visitCompleted todayLiquorice still paused; liniment on one knee and gel on the other
Self-managementLoneliness, costs and transportEvery visitCompleted todayLink worker found a tai chi class; generic medicines in 90-day supplies

Goal progress:

Guideline basis: 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025); 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2019); STEADI: Stopping Elderly Accidents, Deaths, and Injuries (2026); Falls Prevention in Community-Dwelling Older Adults: Interventions (2024); 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol (2018); American Geriatrics Society 2023 Updated AGS Beers Criteria for Potentially Inappropriate Medication Use in Older Adults (2023); Licorice Root (2026); Ginger (2026); CMID: Clinical Monitoring Intelligence Database, hypertension, osteoarthritis and osteoporosis monographs (2026)

Follow-up: Three-month review in nine weeks. Stop chlorthalidone and call if she cannot eat or drink normally. Next scheduled visit 1877-06-15: three-month review after chlorthalidone was stopped: blood pressure above target, losartan added; lipids on atorvastatin; knee and falls. [S]